add new capabl platform
premier number impact account chang impact segment
revenu revenu recognit chang time revenue recogn also
move revenue net basi impact product perform
segment chang impact number year cut estim
net admin fee continu steadi growth stanson acq add clinic
capabl platform push altern payment model strengthen
believ benefit steadi sticki custom base steadi suppli
chain growth posit chang perform segment great posit
view reiter outperform trim pt
report revenu vs estim consensu
adjust ebitda vs consensu estim adj
ep vs estim consensu gpo group
purchas organ net administr fee growth y/i
contract penetr new/exist member
guidanc revis shift end total
revenu guidanc
vs estim consensu revis
adj ebitda guidanc vs estim
consensu compani revis adj ep guid
vs estim consensu segment
acquir stanson health pay cash
earnout close expect end stanson found
ex-ceo cedars-sinai saa cd solut find clinic
equival altern near-real-tim prior author
chang estim account chang due revenue recognit
net basi part busi decreas estim
estim decreas vs
respect model project mid-singl
revenu growth slightli higher
adjust pt pt goe primarili chang net
cash posit b/ valuat multiple/methodolog remain intact
ebitda adj ebitda remain mostli intact
chang chang recogn revenu net basi
impact estim
organ gpo perform
us
analyst certif import disclosur see disclosur
premier outperform gpo busi new
market share growth increas penetr within
custom base recent renew cycl mostli
behind us believ risk significantli decreas on-going
specul amzn potenti entri gpo busi
caus investor concern believ amzn entri
like limit need high-touch servic gpo
busi near term believ recoveri perform
busi key also new guidelin aggress push
risk-bas model could provid lift pinc value-bas
acquisit valuat remain moder integr continu
hiccup
gpo strength continu non-acut etc
acquisit valuat come integr occur ahead
acquisit valuat climb integr continu
adjust pt target decreas slightli primarili due chang net cash posit balanc
sheet valuat multipl methodolog remain intact ebitda adj ebitda estim remain
mostli intact chang chang recogn revenu net basi impact estim
concern price acquisit hinder pinc inorgan growth strategi coupl growth lower margin
busi perform product may hurt overal corpor margin profil
revenu miss ebitda ep end report revenu
vs estim consensu adjust ebitda vs
consensu estim adj ep vs estim consensu
gpo group purchas organ net administr fee growth y/i contract
penetr new/exist member
segment perform perform servic revenu rose y/i vs
consensu estim suppli chain servic revenu y/i vs
consensu estim impact mostli treatment rev net
gross basi direct
gm adj ebitda margin gross margin vs estim
year ago adj ebitda margin vs estim year ago
sg estim
guidanc revis shift end total revenu guidanc
vs estim
consensu suppli chain revis vs
estim consensu perform servic revenu guid revis
vs estim consensu estim revis adj
ebitda guidanc vs estim consensu
compani revis adj ep guid vs estim consensu
quarterli exchang buy-back exchang class unit class
common share slightli larger expect though understand given stock price appreci
didnt get suffici interest company-direct offer member behalf
repurchas share author
acquir stanson health pay cash earnout close expect
end stanson found zynx health ex-ceo cedars-sinai saa
cd solut find clinic equival altern near-real-tim prior author
sale
remeasur tax receiv agreement liabil
amort purchas intang
equiti net incom unconsolid affili
remeasur gain attribut innovatix acq
provis incom tax
net incom attribut non-control interest
compani report oppenheim estim
